Clinical Trial Update: Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating once-daily hydrocortisone for congenital adrenal hyperplasia, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Federico II University | Conditions: Congenital Adrenal Hyperplasia | Phase 4 | Status: RECRUITING